Breadcrumbs Home Investors Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2020-03-23 21:00Moberg Pharma enters financing agreement of up to SEK 216 million for further investments in MOB-015Read more 2020-03-23 08:00All patients in the European MOB-015 Phase 3 study have completed their last visitRead more 2020-02-11 08:00Moberg Pharma AB Interim report October - December 2019Read more 2020-02-04 08:00Moberg Pharma's Interim report to be published on February 11 - Invitation to teleconferenceRead more 2020-01-22 08:00Expert evaluation clarifies Phase 3 results and provides strong support for MOB-015Read more 2020-01-14 08:30The Swedish Tax Agency has published a notification on distribution of the acquisition cost of shares due to the redemption in 2019 of shares in Moberg Pharma AB for cashRead more Pagination First page Previous page … Page 26 Page 27 Page 28 Page 29 Current page 30 Page 31 Page 32 Page 33 Page 34 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2018-11-08 08:30Moberg Pharma's nomination committee appointedRead more 2018-11-06 08:00Moberg Pharma AB Interim report January - September 2018Read more 2018-11-05 08:30Moberg Pharma signs exclusive agreement for Emtrix® in the Middle East and AfricaRead more 2018-10-30 08:00Moberg Pharma's report for the third quarter to be published on November 6 - Invitation to teleconferenceRead more 2018-09-18 08:30Moberg Pharma and Cipher Pharmaceuticals sign exclusive license agreement for MOB-015 in CanadaRead more 2018-09-11 08:30Moberg Pharma has completed enrollment to Phase 3 study for MOB-015 in North AmericaRead more Pagination First page Previous page … Page 26 Page 27 Page 28 Page 29 Current page 30 Page 31 Page 32 Page 33 Page 34 … Next page Last page
